Mesalamine Tablet, Delayed Release
Product Images NDC 0480-7750

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0480-7750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Images 1)

Chemical structure diagram of mesalamine showing a benzene ring with hydroxyl (OH), carboxyl (COOH), and amino (NH2) functional groups attached.*

FDA Label Image

180 (Images 2)

Label for Mesalamine Delayed-Release Tablets, USP 800 mg oral tablets, manufactured by Teva Pharmaceuticals, Inc. The label states the product is for prescription use only and contains 180 tablets. It includes storage instructions, a barcode, NDC number 0480-7750-80, and a note against substituting this product for 800 mg tablets from two 400 mg products.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.